Spots Global Cancer Trial Database for retinal disease
Every month we try and update this database with for retinal disease cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Hematopoietic Stem Cell Transplantation in Autoimmune-Related Retinopathy(ARRON) | NCT00278486 | Retinal Disease | Hematopoietic s... | 18 Years - 60 Years | Northwestern University | |
A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia. | NCT02034006 | Choroidal Neova... | Ranibizumab | 18 Years - | Novartis | |
Hematopoietic Stem Cell Transplantation in Autoimmune-Related Retinopathy(ARRON) | NCT00278486 | Retinal Disease | Hematopoietic s... | 18 Years - 60 Years | Northwestern University |